Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
104 | 4263 | 44.8 | 84% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
461 | 15321 | NEUROPEPTIDE Y//GLUCAGON LIKE PEPTIDE 1//GLP 1 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GLUCAGON LIKE PEPTIDE 1 | Author keyword | 344 | 46% | 13% | 553 |
2 | EXENATIDE | Author keyword | 341 | 70% | 7% | 284 |
3 | LIRAGLUTIDE | Author keyword | 337 | 75% | 6% | 246 |
4 | GLP 1 | Author keyword | 298 | 44% | 12% | 510 |
5 | INCRETIN | Author keyword | 161 | 51% | 5% | 223 |
6 | EXENDIN 4 | Author keyword | 134 | 55% | 4% | 169 |
7 | ALBIGLUTIDE | Author keyword | 81 | 96% | 1% | 25 |
8 | GLUCOSE DEPENDENT INSULINOTROPIC POLYPEPTIDE | Author keyword | 80 | 59% | 2% | 90 |
9 | LIXISENATIDE | Author keyword | 73 | 86% | 1% | 37 |
10 | GIP | Author keyword | 72 | 45% | 3% | 122 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GLUCAGON LIKE PEPTIDE 1 | 344 | 46% | 13% | 553 | Search GLUCAGON+LIKE+PEPTIDE+1 | Search GLUCAGON+LIKE+PEPTIDE+1 |
2 | EXENATIDE | 341 | 70% | 7% | 284 | Search EXENATIDE | Search EXENATIDE |
3 | LIRAGLUTIDE | 337 | 75% | 6% | 246 | Search LIRAGLUTIDE | Search LIRAGLUTIDE |
4 | GLP 1 | 298 | 44% | 12% | 510 | Search GLP+1 | Search GLP+1 |
5 | INCRETIN | 161 | 51% | 5% | 223 | Search INCRETIN | Search INCRETIN |
6 | EXENDIN 4 | 134 | 55% | 4% | 169 | Search EXENDIN+4 | Search EXENDIN+4 |
7 | ALBIGLUTIDE | 81 | 96% | 1% | 25 | Search ALBIGLUTIDE | Search ALBIGLUTIDE |
8 | GLUCOSE DEPENDENT INSULINOTROPIC POLYPEPTIDE | 80 | 59% | 2% | 90 | Search GLUCOSE+DEPENDENT+INSULINOTROPIC+POLYPEPTIDE | Search GLUCOSE+DEPENDENT+INSULINOTROPIC+POLYPEPTIDE |
9 | LIXISENATIDE | 73 | 86% | 1% | 37 | Search LIXISENATIDE | Search LIXISENATIDE |
10 | GIP | 72 | 45% | 3% | 122 | Search GIP | Search GIP |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GLUCAGON LIKE PEPTIDE 1 | 616 | 31% | 39% | 1666 |
2 | GASTRIC INHIBITORY POLYPEPTIDE | 573 | 56% | 16% | 696 |
3 | 7 36 AMIDE | 502 | 81% | 7% | 298 |
4 | EXENDIN 4 | 358 | 68% | 7% | 318 |
5 | DEPENDENT INSULINOTROPIC POLYPEPTIDE | 295 | 59% | 8% | 330 |
6 | GLP 1 | 271 | 47% | 10% | 422 |
7 | EXENATIDE | 207 | 60% | 5% | 223 |
8 | GLP 1 RECEPTOR | 205 | 68% | 4% | 178 |
9 | HUMAN GLP 1 ANALOG | 192 | 83% | 3% | 108 |
10 | GIP | 180 | 65% | 4% | 172 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes | 2006 | 1261 | 81 | 73% |
Biology of incretins: GLP-1 and GIP | 2007 | 1012 | 229 | 78% |
The physiology of glucagon-like peptide 1 | 2007 | 771 | 305 | 80% |
The biology of incretin hormones | 2006 | 858 | 126 | 79% |
Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action | 2013 | 123 | 142 | 71% |
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus | 2012 | 105 | 114 | 96% |
Cardiovascular Biology of the Incretin System | 2012 | 160 | 216 | 60% |
Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? | 2011 | 123 | 63 | 78% |
The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications | 2014 | 19 | 142 | 75% |
Cardiovascular Actions of Incretin-Based Therapies | 2014 | 20 | 125 | 71% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SAAD PHARM DIABET | 28 | 48% | 1.0% | 42 |
2 | NNF BASIC METAB | 20 | 46% | 0.8% | 32 |
3 | INTERNAL MED F | 18 | 28% | 1.3% | 55 |
4 | BANTING BEST DIABET | 15 | 22% | 1.4% | 60 |
5 | LILLY DIABET | 15 | 68% | 0.3% | 13 |
6 | DIABET CLIN NUTR ENDOCRINOL | 9 | 55% | 0.3% | 12 |
7 | DIABET SECT 23 | 8 | 100% | 0.1% | 5 |
8 | CLIN UNIT GASTROINTESTINAL ENDOCRINOL | 7 | 37% | 0.4% | 15 |
9 | METAB NUTR HORMONES | 7 | 43% | 0.3% | 12 |
10 | LAFA | 6 | 80% | 0.1% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000242201 | DPP 4 INHIBITOR//SITAGLIPTIN//VILDAGLIPTIN |
2 | 0.0000117335 | GLUCAGON RECEPTOR//GLUCAGON RECEPTOR GENE//GLUCAGON ANTAGONIST |
3 | 0.0000114175 | PANCREATIC POLYPEPTIDE SECRETION//PANCREATOGENIC DIABETES//GIP RESPONSE |
4 | 0.0000090776 | PEPTIDE YY//PYY//PYY3 36 |
5 | 0.0000075878 | PANCREATIC DIABETES//INSULIN LIKE IMMUNOREACTIVITY//CALCIFYING PANCREATITIS |
6 | 0.0000062041 | GPR40//GPR119//GPR120 |
7 | 0.0000056783 | INSULIN GLARGINE//INSULIN DETEMIR//BIPHASIC INSULIN ASPART 30 |
8 | 0.0000049796 | BETA CELL IMAGING//BETA CELL MASS//DTBZ |
9 | 0.0000044370 | BARIATRIC SURGERY//METABOLIC SURGERY//OBESITY SURGERY |
10 | 0.0000042971 | INDEPENDENT INGESTION//DEVAZEPIDE//A 70104 |